Pharmaceutical Executive, May 2023 Issue (PDF)

Publication
Article
Pharmaceutical ExecutivePharmaceutical Executive: May 2023
Volume 43
Issue 5

Click the title above for a link to open the Pharmaceutical Executive May 2023 issue in an interactive PDF format.

May 2023 Cover
Download Issue PDF
Articles in this issue
Natasha Hernday
From Science to Strategy | 2023 Emerging Pharma Leader
Simon Holland
Committed to the Cause | 2023 Emerging Pharma Leader
Justin To
A Knack for Problem-Solving | 2023 Emerging Pharma Leader
Frank Watanabe
Mission-Fueled Mindset | 2023 Emerging Pharma Leader
Hanadie Yousef
Rejuvenating Lives | 2023 Emerging Pharma Leader
Kyle Forcier
Optimized for Growth? Revenue Management in Pharma
stock.adobe.com
A New Era for Market Access: Organizing the Function’s Broader Strategic Role
Jill Wechsler
Preparing for the End of the COVID Health Emergency
Mike Hollan
AI is a Tool, Not a Replacement for Employees
Geralyn Ritter
Ratings and Rankings: ESG Fundamentals for Pharma Leaders
Barbara Ryan
Will Recent Surge in M&A Dealmaking Save Biotech Sector?
stock.adobe.com
Europe’s Drug Pricing Conundrums Coming to a Head
Meg Rivers
Rise and Recognition
May 2023
Pharmaceutical Executive, May 2023 Issue (PDF)
Recent Videos
Jennifer Kyle, Condor
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Most Effective Strategies to Close the Innovation Gap in Women’s Health
Related Content
© Dr_Microbe - © Dr_Microbe - stock.adobe.com

FDA Approves Expanded Label of Novartis’ Prostate Cancer Treatment, Pluvicto

Andy Studna
March 28th 2025
Article

Based on additional results from the Phase III PSMAfore clinical trial, the therapy is now approved for use prior to chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer.

Peter Ax, UpScriptHealth

Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals

Miranda Schmalfuhs
March 24th 2025
Podcast

Peter Ax, founder & CEO of UpScriptHealth, discusses the impact of tariffs on the pharmaceutical industry and how digital health platforms could potentially help offset them.

Credit: WrightStudio | stock.adobe.com

Oncology Brands Face Uniquely Complex Market Access Challenges: A Specialized Approach for Commercial Success

Shana Gunderson Hua, PharmD; Nancy Pham, PharmD; and Pete Vaccaro
March 28th 2025
Article

The high-stakes nature of cancer care, coupled with rapid scientific advancements, increasing payer and regulatory pressures, demands a specialized approach beyond traditional market access strategies.

Jennifer Butler

The Misinformation Maze: Navigating Public Health in the Digital Age

Miranda Schmalfuhs
March 11th 2025
Podcast

Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.

Pharma Pulse 3/28/25: Emotional Support's Role in Improving Patient Adherence, Drug Shortages and Alternative Sourcing Opportunities & more

Pharma Pulse 3/28/25: Emotional Support's Role in Improving Patient Adherence, Drug Shortages and Alternative Sourcing Opportunities & more

Miranda Schmalfuhs
March 28th 2025
Article

The latest news for pharma industry insiders.

FDA Grants Fast Track Designation to Sanofi’s mRNA Chlamydia Vaccine

FDA Grants Fast Track Designation to Sanofi’s mRNA Chlamydia Vaccine

Don Tracy, Associate Editor
March 28th 2025
Article

As part of the Fast Track designation, Sanofi is set to launch a Phase I/II trial to evaluate the immunogenicity and safety of its novel mRNA vaccine in preventing chlamydia.